Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7761702 | 0.83 | CA1 (0.50) | SMN1; SMN2CA1CA9LMNA | |
| SCHEMBL11649177 | 0.78 | SMN1; SMN2 (0.44) | SMN1; SMN2CA1CA9LMNA | |
| SCHEMBL19778168 | 0.76 | MAPT (0.35) | SMN1; SMN2MAPTLMNAKDM4EALDH1A1 | |
| SCHEMBL1106721 | 0.74 | SMN1; SMN2 (0.40) | SMN1; SMN2CA1CA9 | |
| SCHEMBL14781724 | 0.74 | SMN1; SMN2 (0.40) | SMN1; SMN2CA1CA9LMNA | |
| SCHEMBL27265598 | 0.72 | MAPT (0.33) | MAPTLMNAKDM4EALDH1A1POLB | |
| SCHEMBL9663966 | 0.72 | MAPT (0.33) | MAPT | |
| SCHEMBL12182950 | 0.71 | MAPT (0.32) | MAPT | |
| SCHEMBL10264375 | 0.70 | SMN1; SMN2 (0.36) | SMN1; SMN2CA1CA9 | |
| SCHEMBL7194381 | 0.70 | SMN1; SMN2 (0.40) | SMN1; SMN2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0004978-B1 | USE OF 4,6,6-TRIMETHYLTETRAHYDROPYRAN-2-ONE AND A MIXTURE THEREOF WITH 4,4,6-TRIMETHYLTETRAHYDROPYRAN-2-ONE IN A WEIGHT RATIO OF 60:40 AS FRAGRANCES AND FRAGRANT COMPOSITIONS CONTAINING THEM | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-07-29 | — | — | EP | claimed |
| US-4212773-A | Perfumery compositions with trimethyl-tetrahydropyran-2-ones | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1980-07-15 | — | — | US | claimed |
| US-12577511-B2 | Agent containing emulsifier and microcapsules | HENKEL AG & CO. KGAA (DE) | 2026-03-17 | — | — | US | disclosed |
| US-20240287420-A1 | COMPOSITIONS CONTAINING COLOUR-NEUTRAL DEGRADABLE MICROCAPSULES | HENKEL AG & CO. KGAA (DE) | 2024-08-29 | — | — | US | disclosed |
| EP-4198115-A1 | COMPOSITION COMPRISING EMULSIFIER AND MICROCAPSULES WITH PERFUME COMPOSITION | Henkel AG & Co. KGaA (DE) | 2023-06-21 | — | — | EP | disclosed |
| EP-4198114-A1 | AGENTS CONTAINING EMULSIFIER AND MICROCAPSULES | Henkel AG & Co. KGaA (DE) | 2023-06-21 | — | — | EP | disclosed |
| US-20230183620-A1 | AGENT CONTAINING EMULSIFIER AND MICROCAPSULES | HENKEL AG & CO. KGAA (DE) | 2023-06-15 | — | — | US | disclosed |
| EP-4101529-A1 | COMPOSITION COMPRISING COLOUR-NEUTRAL DEGRADABLE MICROCAPSULES WITH PERFUME COMPOSITION | Henkel AG & Co. KGaA (DE) | 2022-12-14 | — | — | EP | disclosed |
| US-11281100-B2 | Radiation-sensitive resin composition, onium salt compound and method for forming resist pattern | JSR CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| US-20190285983-A1 | RADIATION-SENSITIVE RESIN COMPOSITION, ONIUM SALT COMPOUND AND METHOD FOR FORMING RESIST PATTERN | JSR CORPORATION (JP) | 2019-09-19 | — | — | US | disclosed |
| US-9637497-B2 | Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors | Nerviano Medical Sciences, S.R.L. (IT) | 2017-05-02 | — | — | US | disclosed |
| EP-1167362-A1 | Fragance precursors | Givaudan SA (CH) | 2002-01-02 | — | — | EP | disclosed |
| EP-0401491-A2 | Mixture of isomers of alkyl-methyl-tetrahydropyran-2-ones and a process for their preparation and use | HÜLS AKTIENGESELLSCHAFT (DE) | 1990-12-12 | — | — | EP | disclosed |
| EP-0004978-B1 | USE OF 4,6,6-TRIMETHYLTETRAHYDROPYRAN-2-ONE AND A MIXTURE THEREOF WITH 4,4,6-TRIMETHYLTETRAHYDROPYRAN-2-ONE IN A WEIGHT RATIO OF 60:40 AS FRAGRANCES AND FRAGRANT COMPOSITIONS CONTAINING THEM | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-07-29 | — | — | EP | disclosed |
| EP-0004978-B1 | USE OF 4,6,6-TRIMETHYLTETRAHYDROPYRAN-2-ONE AND A MIXTURE THEREOF WITH 4,4,6-TRIMETHYLTETRAHYDROPYRAN-2-ONE IN A WEIGHT RATIO OF 60:40 AS FRAGRANCES AND FRAGRANT COMPOSITIONS CONTAINING THEM | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-07-29 | — | — | EP | disclosed |
| US-4212773-A | Perfumery compositions with trimethyl-tetrahydropyran-2-ones | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1980-07-15 | — | — | US | disclosed |
| US-4212773-A | Perfumery compositions with trimethyl-tetrahydropyran-2-ones | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1980-07-15 | — | — | US | disclosed |
| EP-0004978-A1 | Use of 4,6,6-trimethyltetrahydropyran-2-one and a mixture thereof with 4,4,6-trimethyltetrahydropyran-2-one in a weight ratio of 60:40 as fragrances and fragrant compositions containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1979-10-31 | — | — | EP | disclosed |
| EP-0004978-A1 | Use of 4,6,6-trimethyltetrahydropyran-2-one and a mixture thereof with 4,4,6-trimethyltetrahydropyran-2-one in a weight ratio of 60:40 as fragrances and fragrant compositions containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1979-10-31 | — | — | EP | disclosed |
| EP-0004978-A1 | Use of 4,6,6-trimethyltetrahydropyran-2-one and a mixture thereof with 4,4,6-trimethyltetrahydropyran-2-one in a weight ratio of 60:40 as fragrances and fragrant compositions containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1979-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577511-B2 | Agent containing emulsifier and microcapsules | LIPA, CUTA, MGLL | SMN1; SMN2 1681/4885CA1 4385/4885CA9 2369/4885 |
| US-20190285983-A1 | RADIATION-SENSITIVE RESIN COMPOSITION, ONIUM SALT COMPOUND AND METHOD FOR FORMING RESIST PATTERN | RER1, RFT1, RAD51 | SMN1; SMN2 1619/4885CA1 699/4885CA9 1273/4885 |
| US-11281100-B2 | Radiation-sensitive resin composition, onium salt compound and method for forming resist pattern | RER1, RFT1, RAD51 | SMN1; SMN2 1619/4885CA1 699/4885CA9 1273/4885 |
| US-20240287420-A1 | COMPOSITIONS CONTAINING COLOUR-NEUTRAL DEGRADABLE MICROCAPSULES | LIPA, CUTA, MGLL | SMN1; SMN2 2356/4885CA1 2406/4885CA9 1018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.